ENU-300

N/A

Report date: 2025/01/26 19:24:28
NME

Base Information

Drug NameENU-300
Drug Alias Namerepurposed drug (Ennaid Therapeutics)ENU-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnnaid Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesEnnaid Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A